This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
No specific inclusion criteria were reported by the authors. Only randomised controlled trials or prospective studies were retained.
Sources searched to identify primary studies
The search was limited to the English-language MEDLINE database from 1966 to 1997.
Criteria used to ensure the validity of primary studies
Not stated.
Methods used to judge relevance and validity, and for extracting data Not stated.
Number of primary studies included
The number of primary studies was approximately 15.
Methods of combining primary studies
Not stated. For the survival probability under standard EMS, the authors chose a study which was a meta-analysis of previous studies.
Investigation of differences between primary studies
Results of the review
Survival rates from hospital admission to discharge and overall survival rates to hospital discharge were estimated to be 32 % (range: 24 -40%) and 8% (range: 0 -25%) respectively. The authors used a relative benefit of PAD of 1.5 (range: 1.05 -2.2). Life expectancy and utility levels of survivors of cardiac arrest were 5.61 (range: 4.79 -6.62) and 0.72 (range: 0.68 -0.78), respectively.
Measure of benefits used in the economic analysis
The measure of benefits used was Quality Adjusted Life Years (QALYs). The quality of life of survivors of cardiac arrest was estimated from a previously published study.
Direct costs
The quantity/cost boundary adopted was that of society at large. Direct costs included the purchase cost of an automated external defibrillator, annual training and maintenance costs, the cost of police defibrillation and hospitalisation costs. The cost of treatment by EMS (common to both strategies) and future costs were not included. Quantities were not reported separately from prices.
Statistical analysis of costs
Indirect Costs
Not assessed.
